Stock 600976 JIANMIN PHARMACEUTICAL GROUP CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Jianmin Pharmaceutical Group Co.,Ltd.

Equities

600976

CNE000001HB7

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
56.35 CNY +1.28% Intraday chart for Jianmin Pharmaceutical Group Co.,Ltd. -0.74% -13.64%
Apr. 19 Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 16 Jianmin Pharma Gets Nod to Market Asthma Drug MT

Business Summary

JIANMIN PHARMACEUTICAL GROUP CO., LTD., formerly Wuhan Jianmin Pharmaceutical Groups Co. Ltd, is a China-based company, principally engaged in the research and development, manufacture, wholesale and retailing of pharmaceuticals. The Company operates its businesses through two segments, including Pharmaceutical Industry and Pharmaceutical Business. The Pharmaceutical Industry segment is engaged in the research and development and manufacture of pharmaceuticals. Its products are mainly applied in children, women and the elderly, among others. The Pharmaceutical Business segment is engaged in the wholesale and retailing of pharmaceuticals. Its products include traditional Chinese medicine, Western medicine, health products, medical equipment and chemical agents. It distributes its products mainly in domestic market.

Number of employees: 2,497

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical Production
98.8 %
3,561 97.8 % 4,163 98.8 % +16.89%
Commercial
48.8 %
1,754 48.2 % 2,056 48.8 % +17.21%
Inter-segment Elimination
-48.0 %
-1,695 -46.5 % -2,021 -48.0 % +19.24%
Medical
0.4 %
20 0.6 % 15 0.4 % -24.66%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
3,641 100.0 % 4,213 100.0 % +15.72%

Managers

Managers TitleAgeSince
Jun Wang CEO
 Chief Executive Officer 48 20-09-08
Zhao Yang Cheng DFI
 Director of Finance/CFO 52 18-01-01
Qin He CHM
 Chairman 64 03-12-31
Jin Qiu Tang ADM
 Chief Administrative Officer 51 22-08-31
Fang Jing Huang BRD
 Director/Board Member 38 22-08-31
Li Chen BRD
 Director/Board Member 54 13-09-05
Hong Cao IRC
 Investor Relations Contact 41 -
Jie Zhou SEC
 Corporate Secretary 46 -
Zhen Bo Hu PRN
 Corporate Officer/Principal 53 -

Members of the board

Members of the board TitleAgeSince
Qin He CHM
 Chairman 64 03-12-31
Shu Qu Li BRD
 Director/Board Member 53 19-09-04
Si Yang Wang BRD
 Director/Board Member 37 11-06-30
Rong Pei BRD
 Director/Board Member 53 11-08-02
Yun Pei Guo BRD
 Director/Board Member 76 22-08-31
Qi Jing Xiao CHM
 Chairman 59 19-09-04
Li Chen BRD
 Director/Board Member 54 13-09-05
Jian Hu BRD
 Director/Board Member 56 19-09-04
Liang Xu BRD
 Director/Board Member 51 18-03-26
Jun Wang CEO
 Chief Executive Officer 48 20-09-08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 153,398,600 106,053,799 ( 69.14 %) 449,000 ( 0.2927 %) 69.14 %

Shareholders

NameEquities%Valuation
Holley Group Co., Ltd.
27.63 %
42,112,614 27.63 % 337 M ¥
ICBC Credit Suisse Asset Management Co., Ltd.
7.734 %
11,786,100 7.734 % 94 M ¥
GF Fund Management Co., Ltd.
3.503 %
5,338,761 3.503 % 43 M ¥
Hui Ming Sun
2.668 %
4,066,630 2.668 % 33 M ¥
Zhong Ou Asset Management Co., Ltd
2.352 %
3,584,387 2.352 % 29 M ¥
Fullgoal Fund Management Co., Ltd.
2.283 %
3,479,751 2.283 % 28 M ¥
China Southern Asset Management Co., Ltd.
0.9088 %
1,384,944 0.9088 % 11 M ¥
China Merchants Fund Management Co., Ltd.
0.9047 %
1,378,791 0.9047 % 11 M ¥
China Asset Management Co., Ltd.
0.7068 %
1,077,097 0.7068 % 9 M ¥
Great Wall Fund Management Co., Ltd.
0.7050 %
1,074,400 0.7050 % 9 M ¥

Company contact information

Jianmin Pharmaceutical Group Co., Ltd.

484 Parrot Avenue Hanyang District

430052, Wuhan

+

http://www.whjm.com
address Jianmin Pharmaceutical Group Co.,Ltd.(600976)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Jianmin Pharmaceutical Group Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
56.35 CNY
Average target price
87.74 CNY
Spread / Average Target
+55.71%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
JIANMIN PHARMACEUTICAL GROUP CO.,LTD. Stock Jianmin Pharmaceutical Group Co.,Ltd.
-13.64% 1.17B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.47% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.35% 332B
ABBVIE INC. Stock AbbVie Inc.
+4.23% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.43% 231B
NOVARTIS AG Stock Novartis AG
+4.71% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.53% 195B
AMGEN INC. Stock Amgen Inc.
-4.04% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600976 Stock
  4. Company Jianmin Pharmaceutical Group Co.,Ltd.